Explore more publications!

Watch The European's interview with Juergen Nelis of BGG World

LONDON, ENGLAND, UNITED KINGDOM, January 19, 2026 /EINPresswire.com/ -- Influencer-driven growth in natural wellness is prompting BGG World to broaden its production base and hedge against trade disruption, with microalgae bioproduction forming a core part of its expansion strategy

TikTok and Instagram are reshaping consumer behaviour around health and nutrition, and driving a surge in demand for natural supplements worldwide, according to China’s BGG World.

Juergen Nelis, its chief executive, said influencers are reshaping global demand for wellness products at an unprecedented rate not seen since the outbreak of Covid-19.

Speaking in a studio interview with The European, he said more consumers than ever before are adopting daily preventive routines rather than waiting for symptoms, with social platforms pushing new supplement trends into the mainstream and influencing purchasing decisions at speed.

The United States and Asia now lead the market for natural health ingredients, followed by Europe, which is expanding at a steadier pace due to more restrictive health-claim rules and a more cautious approach to supplementation.

Nelis described the pandemic as the point at which natural wellness entered mass consumer culture. That initial phase has been followed by a sharper spike driven by social platforms, which he said are amplifying awareness and accelerating adoption.

“The market has developed significantly and that has come about because of the awareness of consumers about their own health and how they can support it without being treated for a disease,” he said.

“Social media and influencers, together with better access to ecommerce, have made a big difference.”

BGG World, founded in Beijing in 1995, is one of the world’s largest suppliers of natural ingredients, operating across Asia, Europe and the United States.

From its international headquarters in Switzerland, it has grown into a multinational group supplying plant and microalgae-derived actives used in supplements, functional foods and cosmetics.

Nelis also used the interview to outline its plans to expand its manufacturing footprint in additional regions and to scale microalgae-based bioproduction for ingredients such as astaxanthin.

The aim, he said, is to build production capacity in additional regions so the group is less exposed to geopolitical and trade disruptions. “On the long term our strategy will be to further hedge and further globalise the company,” he said. “We want to build manufacturing capabilities in different regions so we are more agile and less impacted.”

Microalgae cultivation, he added, remains central to that strategy. Single-cell organisms are grown in enclosed photobioreactors and stressed to produce high-value actives, including astaxanthin, which Nelis described as “one of the strongest antioxidants that exists” with production of roughly ten metric tonnes a year.

The platform feeds a pipeline of ingredients for supplement, functional food and topical manufacturers, with product development beginning at end-user level. “It starts with the consumer,” he said.

Collaboration with research institutions in China, Japan and Switzerland supports the firm’s R&D work, together with clinical studies undertaken by contract research organisations.

Nelis said the outlook remains positive as preventive health, influencer culture and science-based nutrition continue to converge. “Our vision is clear,” he said. “We want to help people feel good, be healthy and powerful.”

Watch Juergen Nelis’ full interview on The European’s YouTube channel.

C Nugent-Isitt
CP Media Global
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions